These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antibody to Epstein-Barr virus-specific DNase as a marker for the early detection of nasopharyngeal carcinoma. Chen JY, Liu MY, Chen CJ, Hsu MM, Tu SM, Lee HH, Kuo SL, Yang CS. J Med Virol; 1985 Sep; 17(1):47-9. PubMed ID: 2995572 [Abstract] [Full Text] [Related]
6. Antibody to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma. Chen JY, Liu MY, Lynn TC, Yang CS. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Nov; 15(4):255-61. PubMed ID: 6305599 [Abstract] [Full Text] [Related]
14. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups. Lin TM, Yang CS, Chiou JF, Tu SM, Chen TY, Tu YC, Lin PJ, Kawamura A, Hirayama T. Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059 [Abstract] [Full Text] [Related]
16. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan. Yang X, Goldstein AM, Chen CJ, Rabkin CS, Chen JY, Cheng YJ, Hsu WL, Sun B, Diehl SR, Liu MY, Walters M, Shao W, Ortiz-Conde BA, Whitby D, Elmore SH, Gulley ML, Hildesheim A. Int J Cancer; 2006 Feb 01; 118(3):780-4. PubMed ID: 16106400 [Abstract] [Full Text] [Related]